Enliven Therapeutics Inc (ELVN)
24.02
+0.21
(+0.88%)
USD |
NASDAQ |
May 20, 16:00
24.02
0.00 (0.00%)
After-Hours: 20:00
Enliven Therapeutics Total Assets (Quarterly): 342.78M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 342.78M |
| December 31, 2023 | 271.87M |
| September 30, 2023 | 274.04M |
| June 30, 2023 | 288.50M |
| Date | Value |
|---|---|
| March 31, 2023 | 302.87M |
| December 31, 2022 | 83.30M |
| September 30, 2022 | 90.80M |
| December 31, 2021 | 113.33M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
83.30M
Minimum
Dec 2022
342.78M
Maximum
Mar 2024
220.93M
Average
272.95M
Median
Total Assets (Quarterly) Benchmarks
| Eyenovia Inc | 26.18M |
| Phathom Pharmaceuticals Inc | 356.50M |
| Lantern Pharma Inc | 39.73M |
| Vincerx Pharma Inc | 11.08M |
| NKGen Biotech Inc | 16.48M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 25.06M |
| Shareholders Equity (Quarterly) | 317.71M |